No abstract available
Keywords:
LDL‐C; diabetes; ezetimibe; lipids; prevention.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anticholesteremic Agents* / adverse effects
-
Diabetes Mellitus* / drug therapy
-
Diabetes Mellitus* / epidemiology
-
Drug Therapy, Combination
-
Ezetimibe / therapeutic use
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Substances
-
Ezetimibe
-
Anticholesteremic Agents
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors